Literature DB >> 17132777

Embryonic heart induction.

Ann C Foley1, Ruchika W Gupta, Rosa M Guzzo, Oksana Korol, Mark Mercola.   

Abstract

We have characterized two signaling pathways that induce heart tissue during embryonic development. The first is initiated by the Wnt antagonist Dickkopf1 (Dkk1) and involves the homeodomain transcription factor Hex. Other Wnt antagonists are less effective and the potency of Dkk1 might be due to synergy between Wnt antagonizing and another, novel activity emanating from its amino terminal cysteine-rich domain. The second signal is initiated by Nodal and its co-receptor Cripto. Importantly, both the Dkk1/Wnt antagonism and Nodal pathways act on the endoderm that underlies the future heart to control secretion of diffusible factors that induce cardiogenesis in adjacent mesoderm. In this article, we summarize data that Dkk1 induces cardiogenic differentiation cell non-autonomously through the action of the homeodomain transcription factor Hex. We also discuss recent data showing that Nodal also acts indirectly through stimulation of the secreted protein Cerberus, which is a member of the differential-screening selected aberrant in neuroblastoma (DAN) family of secreted proteins. Finally, we present the model that signaling from Dkk1 regulates novel activities, in addition to Wnt antagonism, which are essential for progression beyond initiation of cardiogenesis to control later stages of cardiomyocyte differentiation and myocardial tissue organization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132777     DOI: 10.1196/annals.1380.008

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  sonic hedgehog is required in pulmonary endoderm for atrial septation.

Authors:  Andrew D Hoffmann; Michael A Peterson; Joshua M Friedland-Little; Stuart A Anderson; Ivan P Moskowitz
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

2.  Embryonic Stem Cells as a Model for Cardiac Development and Disease.

Authors:  Todd Evans
Journal:  Drug Discov Today Dis Models       Date:  2008

3.  Canonical WNT signaling enhances stem cell expression in the developing heart without a corresponding inhibition of cardiogenic differentiation.

Authors:  Lisa K Martin; Nadejda V Mezentseva; Momka Bratoeva; Ann F Ramsdell; Carol A Eisenberg; Leonard M Eisenberg
Journal:  Stem Cells Dev       Date:  2011-04-03       Impact factor: 3.272

4.  Tmem88a mediates GATA-dependent specification of cardiomyocyte progenitors by restricting WNT signaling.

Authors:  Natasha Novikov; Todd Evans
Journal:  Development       Date:  2013-07-31       Impact factor: 6.868

Review 5.  Myocardial lineage development.

Authors:  Sylvia M Evans; Deborah Yelon; Frank L Conlon; Margaret L Kirby
Journal:  Circ Res       Date:  2010-12-10       Impact factor: 17.367

Review 6.  Electrophysiological challenges of cell-based myocardial repair.

Authors:  Huei-Sheng Vincent Chen; Changsung Kim; Mark Mercola
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

7.  Gata4 directs development of cardiac-inducing endoderm from ES cells.

Authors:  Audrey Holtzinger; Gabriel E Rosenfeld; Todd Evans
Journal:  Dev Biol       Date:  2009-10-20       Impact factor: 3.582

8.  A novel activity of the Dickkopf-1 amino terminal domain promotes axial and heart development independently of canonical Wnt inhibition.

Authors:  Oksana Korol; Ruchika W Gupta; Mark Mercola
Journal:  Dev Biol       Date:  2008-09-24       Impact factor: 3.582

9.  New Ligand Binding Function of Human Cerberus and Role of Proteolytic Processing in Regulating Ligand-Receptor Interactions and Antagonist Activity.

Authors:  Senem Aykul; Erik Martinez-Hackert
Journal:  J Mol Biol       Date:  2016-01-21       Impact factor: 5.469

10.  eXtraembryonic ENdoderm (XEN) stem cells produce factors that activate heart formation.

Authors:  Kemar Brown; Michael Xavier Doss; Stephanie Legros; Jérôme Artus; Anna-Katerina Hadjantonakis; Ann C Foley
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.